600488 Tianjin Tianyao Pharmaceuticals
- 3.88
- 0.000.00%
Tianjin Tianyao Pharmaceuticals News
Announcement of Jinyao Pharmaceutical Co., Ltd. on participating in the 2024 semi-annual report performance briefing session for listed companies under the jurisdiction of Tianjin and an online group reception day for investors
Announcement on transactions related to the renewal of the “Equity Custody Agreement” between Tianjin Pharmaceutical Co., Ltd. and Jinyao Asset Management Co., Ltd.
Announcement of Resolutions of the Eighth Meeting of the 9th Board of Supervisors of Tianjin Pharmaceutical Co., Ltd.
Announcement on related transactions between Tianjin Pharmaceutical Co., Ltd. and Tianjin Pharmaceutical Group Co., Ltd. renew the “Equity Custody Agreement”
Risk Continuity Assessment Report of Tianjin Pharmaceutical Co., Ltd. on Tianjin Pharmaceutical Group Finance Co., Ltd.
Information Disclosure Management System for Tianjin Pharmaceutical Co., Ltd. (Revised in August 2024)
Announcement of Resolutions of the 10th Meeting of the 9th Board of Directors of Tianjin Pharmaceutical Co., Ltd.
Tianjin Tianyao Pharmaceuticals: Announcement on Tianjin Tianyao Pharmaceuticals Co., Ltd.'s subsidiary adding new specifications for pharmaceutical products and passing the consistency evaluation of generic drugs.
Announcement of the resolution of the 7th meeting of the 9th Board of Supervisors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Announcement of Related Trade between Tianjin Tianyao Pharmaceuticals Co., Ltd. and Tianjin Tianyao Biotechnology Co., Ltd.
Tianjin Tianyao Pharmaceuticals Co., Ltd. Articles of Association (July 2024)
Announcement of the Ninth Meeting of the Ninth Board of Directors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Announcement of the resolution of the sixth meeting of the ninth session of the Board of Supervisors of Tianjin TiaNiao Pharmaceuticals Co., Ltd.
Announcement of the resolution of the 8th meeting of the 9th board of directors of Tianjin Tianyao Pharmaceuticals Co., Ltd.
Announcement of Tianjin Pharmaceutical Co., Ltd. on the holding of the 2023 annual results briefing
Announcement of Jinyao Pharmaceutical Co., Ltd. on obtaining the CEP certificate for the active ingredient betamethasone dipropionate
Announcement of Tianjin Pharmaceutical Co., Ltd. on holding the 2023 Annual Results Briefing
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Tianjin Pharmaceutical Co., Ltd.
Announcement of Resolutions of the Fifth Meeting of the 9th Board of Supervisors of Tianjin Pharmaceutical Co., Ltd.
Announcement of Tianjin Pharmaceutical Co., Ltd. on changing the secretary of the board
Analysis
Price Target
No Data
